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This book is edited by Dr. Mike S. Lee, who is currently
the President of Milestone Development Services. Ac-
cording to the Preface, the book is based on a special
issue of Curr. Top. Med. Chem., which was published in
January 2002 (Volume 2, Number 1). The book consists
of 18 chapters written by respected colleagues in the
field and covers a compendium of useful topics with an
emphasis on industrial applications of MS. Citations in
most chapters are relatively recent and the subject
indexing is adequate. There is something in this book
for everyone interested in industrial applications of
biological MS in drug discovery. This book will be
particularly beneficial to the new MS users (non-ex-
perts), presenting them an introductory and easy-to-
read, yet broad and not superficial, overview of the
field.
Chapter 1 discusses the low flow rate ESI for minia-
turized applications in small and large molecule analy-
sis. Brief discussions on static and on-line nanospray
approaches, sample injection, mobile phase delivery,
and MS interface are provided. Topics such as
bottom-up and top-down protein analysis in localiza-
tion of posttranslational modifications are mentioned.
In this section, I would have liked to see a brief
discussion on top-down fragmentation and an example
of an ECD-FT-ICR-MS experiment from the authors’
laboratory.
Chapter 2 gives a general survey of MS-based drug
discovery screening assays with a focus on gas-phase
noncovalent analysis with examples on protein-drug,
RNA-drug, and DNA-drug complexes. ESI-MS based
condensed phase screening studies using frontal affin-
ity chromatography, affinity centrifugal ultrafiltration,
pulsed ultrafiltration, ultracentrifugation, gel perme-
ation chromatography, and affinity CE are discussed.
The chapter also describes the applications of
MALDI-MS using affinity probes, in conjunction with
flow cytometry, and a brief reference to H/D exchange
screening of protein-ligand complexes using MALDI.
The conclusion segment of this chapter outlines the
advantages and disadvantages (e.g., false positives dur-Published online December 15, 2005
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(J Am Soc Mass Spectrom 2006, 17, 108–110)ing screening) of using a MS-based approach for inves-
tigation of specific noncovalent complexes.
Chapter 3 covers the applications of ESI-FT-ICR-MS
using multitarget affinity/specificity screening (MASS)
for the analysis of RNA-drug noncovalent complexes.
Small RNA sub-domains that mimic the active (func-
tional) domain of ribosomal RNA are constructed and
analyzed using MASS in two fashions. Initially, high-
throughput MS screening of naturally or synthetic
combinatorial libraries is performed to fish out the
compounds that bind to the target rRNA. Subsequently,
the dissociation constants of the lead candidates are
determined for SAR evaluations. This chapter contains
a number of examples, clear descriptions on the exper-
imental procedures, and their corresponding algo-
rithms for data reporting.
Chapter 4 deals with the “emerging” topic of
proteomics-based biomarker discovery for disease di-
agnosis. Recent advancements in genomics and pro-
teomics have generated considerable interest in discov-
ery and validation of biomarkers in the mechanism-
based drug development. The main focus of this
chapter is the utility of protein chip arrays in SELDI-
TOF-MS, followed by several clinical examples using
the PBS-II (low-resolution) and Qq-TOF mass spectrom-
eters (high-resolution). Authors conclude the chapter
with advantages and pitfalls of the proteomics-based
biomarker discovery. Issues such as specificity and
sensitivity warrant additional improvement before the
MS-based proteomic screening can be considered a
“routine” tool in diagnostic medicine.
Chapter 5 is in some aspects complementary to
Chapter 4 and covers metabonomic applications in
toxicity screening and disease diagnosis. The chapter is
nicely organized and discusses the use of NMR and
magic-angle spinning (MAS) NMR spectroscopy in
conjunction with principal components analysis (PCA)
to characterize metabolic markers in urine and intact rat
renal papilla samples, respectively. Several multivariate
models and their applications in data mining and
interpretation are discussed, with associated figures
and plots. Table 5.1 is particularly useful in capturing
some of the current metabolic markers associated with
various toxins, identified via metabonomic analysis.
Chapter 6 describes the applications of MS in natural
product discovery and the complexity of biologically
active compound identification in complex mixtures.
The utility of automated purification approaches such
as SepBox (HPLC/SPE/HPLC/SPE) in combination
with MS-based screening are discussed. Authors
present examples on data-dependent MSn, LC-MS/
NMR, and high-resolution MS (e.g., Q-TOF and FT-
ICR-MS), for structure elucidation.
Chapters 7 and 8 discuss, at length, the role of MS in
combinatorial chemistry. The two chapters complement
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number of topics such as library purification, flow-
injection analysis MS, open-access MS, fast LC-MS,
parallel runs (e.g., multiple columns, multiple spray-
ers), SFC-MS, and CE-MS approaches. Chapter 7 could
have been more educational to nonspecialists if it had
contained some diagrams, figures, or tables to convey
the technical aspects of its theme. Chapter 8 describes
the construction of combinatorial library and mass-
tagging techniques for encoding/decoding. To this end,
a number of useful figures and diagrams on mass-
encoding, “split-mix-recombine”, photo-cleavable link-
ers, and the use of stable isotope for MS signature
construct are presented. Several pages at the end of the
chapter are devoted to statistical decoding and data
mining with relevant illustrations.
Chapter 9 covers the methodological advances in
drug metabolism (ADME) studies. The authors present
an updated, clear overview of hardware and software
applications including LC-NMR, accelerated mass spec-
trometry (AMS), microfluidic devices, and linear ion
trap MS platforms. This chapter would have been even
better than its current form if it had contained figures
and/or tables on some of the techniques (i.e., field
asymmetric-waveform ion-mobility spectrometry, Sciex
Qtrap, LC-NMR, lab-on-a-chip) discussed therein.
Chapter 10 focuses on characterization of reactive
intermediates (this topic is of relevance in investigation
of drug elicited toxicity) using a combination of site-
specific chemical trapping (e.g., GSH, Lys-Phe, dansy-
laziridine) in conjunction with LC-MS/MS at the early
stages of drug discovery screening (without the use of
radiolabeled compounds). Test cases using loxapine,
diclofenac, quinidine, ticlopidine, and troglitazone are
presented with a number of educational figures (prod-
uct ion spectra) and mechanistic schemes. Topics such
as acyl glucuronide (AG) reactivity/rearrangement,
glutathione trapping, solution deuterium exchange ex-
periments, and protein covalent binding are discussed
in a succinct fashion. A number of product ion spectra
are shown with their corresponding structural assign-
ments.
Chapters 11 and 12 are well written with a number of
practical discussions (kitchen tricks) on quantitative
bioanalysis in drug discovery. In Chapter 11, the reader
is methodically introduced to ionization schemes, mass
analyzers, on-line sample analysis, off-line sample
preparation, fast gradient, monolithic columns, ioniza-
tion suppression, metabolite interference, and cross-
talk. The text is written well with more than 130
citations and a number of illustrations and schematics.
Chapter 12 is a continuation of a similar theme but with
a focus on pharmacokinetic applications and typical
issues encountered during lead optimization. Ap-
proaches such as cassette-accelerated rapid rat screen
(CARRS) and dosing vehicle mediated ionization sup-
pression are presented. I would have liked to see a little
more depth and discussions on the latter subject matter
involving the “dosing vehicle” mediated ionizationsuppression. This topic is becoming an important issue
(i.e., based on several recent published reports), which
at times leads to dramatic masking effects on the
post-dose pharmacokinetics samples when using the
so-called low k= LC-ESI-MS runs.
Chapter 13 contains LC-MS based strategies for
pharmaceutical profiling purposes. A host of topics
including chemical stability, purity, and in vitro meta-
bolic stability using LC-MS and LC/UV/MS with soft-
ware illustrations are covered. The application of
LC-MS in studies using the parallel artificial membrane
permeability assay (PAMPA) to possibly predict the
passive intestinal permeability is discussed. Metabolic
stability studies using liver microsomal (rat, human,
and mouse) assays in a 96-well plate format conclude
this chapter.
High-throughput screening (HTS) studies specific to
medicinal chemistry needs are the focus of Chapter 14.
Highly hyphenated techniques (e.g., LC/UV/MS/
NMR, LC/UV/CLND/MS, SFC-MS) for sample char-
acterization and impurity identification are discussed
along with two related tables that capture the pros and
cons of each experiment. Examples, on the Symyx
automated workstation and supercritical fluid chroma-
tography are presented for solubility (solubility pro-
files, polymorph forms, and salt formulations) and
purification purposes, respectively. The chapter con-
cludes with a brief reference to the newly introduced
nanostream microfluidic cartridge with 24 LC separa-
tion channels.
Chapter 15 is another segment focusing on pharma-
ceutical profiling, which contains informative tables
with an overall presentation on determination of mul-
tivariate property at early and mid stages of drug
discovery. This chapter is useful to the readers who
would prefer to become familiar with pharmaceutical
profiling and hit optimization without going into in-
strumental and other technical details. To this end,
several informative tables summarize the applications,
hurdles, and relevant assay attributes.
Chapter 16 deals with mass spectrometry applica-
tions in organ perfusion studies (the vascularly per-
fused intestine, liver, kidney, etc.). Clear and concise
discussions on the gut model (absorption into blood),
liver (first pass clearance), kidney (renal clearance),
lung (absorption from airways), and brain (uptake from
blood) are presented with relevant citations. Fortu-
nately, the focus on the LC-MS platforms is confined to
a minimum, to avoid redundancy and overlap with
other chapters.
Chapter 17 complements Chapter 11 on sample prep-
aration strategies including protein precipitation, liquid-
liquid extraction, solid-phase extraction, restricted-access
media, and turbulent flow chromatography.
The book concludes with Chapter 18 on automa-
tion, briefly covering a host of topics such as bar
coding for sample tracking (DataMatrix), data acqui-
sition, data archiving (with consideration to FDA’s
CFR Part 11), scripting robotics, LIMS, Microsoft.Net,
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Overall, this textbook is easy-to-read, clearly orga-
nized, and well written by established colleagues in the
field. In most cases, authors’ bias toward the subject
matter was minimal. Therefore, throughout the book,
pitfalls and advantages are brought to the reader’s
attention. In retrospect, if space were not an issue, two
more chapters would have made this collection com-
plete. One chapter could have dealt with the opera-
tional basics (without going into design and mathemat-ical details) of linear ion traps, LTQ-FT-ICR-MS,
Orbitrap, TOF-TOF, and any other relatively recent
mass analyzer. The other chapter would have focused
on assay development and important issues in sample
preparation, mobile phase, column, and MS ionization
selection in chiral (enantiomeric) LC-MS in support of
drug development. Nonetheless, I highly recommend
this book as a supplement in a graduate course on
bioanalytical chemistry, in a Pharmacy/Pharmaceutics
curriculum, and for use by industrial scientists who are
“new” to the field.
